SCHEMBL19981541

SCHEMBL19981541

COP(C)(=O)N1CCN(C(=O)CCC(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.38
ALDH1A1 P00352 7/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
RECQL P46063 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.34
POLB P06746 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20019726 0.91 ATM (0.42) ALDH1A1SMN1; SMN2HSD17B10KDM4EMEN1
SCHEMBL15030738 0.84 L3MBTL1 (0.40) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL19981499 0.80 SMN1; SMN2 (0.35) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL20885121 0.76 ALDH1A1 (0.56) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL14654985 0.76 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2HSD17B10KDM4EMEN1
SCHEMBL15871575 0.75 ATM (0.39) ALDH1A1SMN1; SMN2HSD17B10KDM4EMEN1
SCHEMBL25775999 0.74
SCHEMBL3242393 0.71 SMN1; SMN2 (0.51) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL6499575 0.71 TDP1 (0.48) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL408997 0.71 USP2 (0.34) USP2ALDH1A1SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed